Get started
Author

Alain Spriet

Observed names: A SPRIET, A Spriet, A. Spriet, Alain SPRIET, Spriet, Alain, Simon, Pierre
OpenAlex ID: A5109192501
Table to facilitate determination of symmetrical confidence intervals in bioavailability trials with Westlake’s method
1978 · Alain Spriet, Daniel Beiler · European Journal of Drug Metabolism and Pharmacokinetics · 30
When can 'non significantly different' treatments be considered as 'equivalent'?
1979 · A Spriet, D Beiler · British Journal of Clinical Pharmacology · 29
PDF
[Assessment of preventable iatrogenic drug therapy: methodology. Round Table No 2 at Giens XIII].
1998 · J L Imbs, Y Pletan, et al. · PubMed · 26
Adherence of elderly patients to treatment with pentoxifylline
1980 · Alain Spriet, Daniel Beiler, et al. · Clinical Pharmacology & Therapeutics · 22
Methodology of Clinical Drug Trials.
1995 · Ralph B. D'Agostino, Alain Spriet, et al. · Journal of the American Statistical Association · 19
The Respective Roles of Controlled Clinical Trials and Cohort Monitoring Studies in the Pre- and Postmarketing Assessment of Drugs
2005 · Muriel Vray, Bernard Hamelin, et al. · Therapies · 17
Place relative des essais cliniques comparatifs et des suivis de cohorte dans l’évaluation préet post-AMM des médicaments
2005 · Muriel Vray, Bernard Hamelin, et al. · Therapies · 16
Methodology and results of a survey of adverse reactions to a drug in private practice
1977 · A. Spriet, C. Spriet, et al. · European Journal of Clinical Pharmacology · 15
Quantification methods were developed for selection bias by predictability of allocations with unequal block randomization
2005 · T DUPINSPRIET, J FERMANIAN, et al. · Journal of Clinical Epidemiology · 13
Methodology of clinical drug trials / Contents
2015 · Alain Spriet, Pierre Simon · KARGER eBooks · 10
Quantification of Predictability in Clinical Trials Using Block Randomization
2004 · Thérèse Dupin-Spriet, Jacques Fermanian, et al. · Drug Information Journal · 10
How to Improve the Clinical Development Paradigm and its Division into Phases I, II and III
2011 · Marion Bamberger, Nicholas Moore, et al. · Therapies · 8
Menopause-related change in plasma viscosity
1988 · C. Bonithon-Kopp, P.Y. Scarabin, et al. · Clinical Hemorheology and Microcirculation · 7
Good Biometric Practice Proposals for a Set of Procedures
1992 · Alain Spriet, Thérèse Dupin-Spriet · Drug Information Journal · 6
Value of Post-Registration Studies for Reimbursement Renewal
2009 · Mathieu Molimard, Marion Bamberger, et al. · Therapies · 5
PDF
Études post-AMM : apport dans la réinscription des produits
2009 · Mathieu Molimard, Marion Bamberger, et al. · Therapies · 4
Sample Size for Linear and Quadratic Terms in a Dose-Response Relationship
1996 · Alain Spriet, Thérèse Dupin-Spriet · Drug Information Journal · 4
[Pentoxifylline and intermittent claudication: critical analysis of clinical trials].
1995 · O L Charansonney, A Spriet · PubMed · 4
Imperfect Data Analysis
1993 · Alain Spriet, Thérèse Dupin-Spriet · Drug Information Journal · 4
Variance comparison as a tool in clinical pharmacology: An example with two loop diuretics
1982 · J. L. Imbs, M. Schmidt, et al. · European Journal of Clinical Pharmacology · 3
[Hypoglycemia in the newborn with microcephalus, macroglossia and megalosplanchnia].
1968 · R Mariani, D Unal, et al. · PubMed · 3
3. selection of subjects
2015 · A. Spriet, P. Simon · KARGER eBooks · 2
The Conduct of Clinical Trials for Medicinal Products in Europe in the Light of the European Clinical Trials Directive. Review of Regulatory and Practical Aspects in the Different Countries
2007 · Claude Dubray, Patricia Maillere, et al. · Therapies · 2
Conduite des essais cliniques de médicaments au niveau européen depuis la directive européenne essais cliniques. Revue des aspects réglementaires et pratiques dans différents pays
2007 · Claude Dubray, Patricia Maillere, et al. · Therapies · 2
[Women in clinical trials].
1995 · M J Gérard-Coué, G Bréart, et al. · PubMed · 2
Works count: 70
Citation count: 281
H-index: 10
I10-index: 11
Year
Topic
Type